enVVeno Medical (NVNO) Operating Expenses (2017 - 2026)

enVVeno Medical's Operating Expenses history runs 10 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 18.01% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $20.0 million, a 14.05% decrease from a year earlier, with the FY2025 full-year figure at $20.9 million, down 12.28% from the prior year.
• Operating Expenses advanced to $4.1 million in Q1 2026 per NVNO's latest filing, from $4.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $7.0 million in Q2 2025 and bottomed at $4.0 million in Q4 2025.
• The 5-year median for Operating Expenses is $6.2 million (2022), against an average of $5.8 million.
• Across the five-year window, Operating Expenses soared 192.79% in 2022 and tumbled 40.1% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $6.5 million in 2022, then slipped by 2.82% to $6.3 million in 2023, then rose by 6.71% to $6.7 million in 2024, then tumbled by 40.1% to $4.0 million in 2025, then gained by 1.22% to $4.1 million in 2026.
• Per Business Quant, the three latest NVNO Operating Expenses figures stand at $4.1 million (Q1 2026), $4.0 million (Q4 2025), and $4.9 million (Q3 2025).